Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil - Taniguchi, Keiichi; Ando, Yoshinori; Nobori, Haruaki; Toba, Shinsuke; Noshi, Takeshi; Kobayashi, Masanori; Kawai, Makoto; Yoshida, Ryu; Sato, Akihiko; Shishido, Takao; Naito, Akira; Matsuno, Keita; et al. (Scientific reports, 2019)
Keywords: 13/106; 13/21; 631/154/436/2388; 64/60; 692/700/565/1436/2774; Amino acids; Animals; Antiviral Agents - pharmacology; Antiviral drugs; Avian flu; Cell culture; Cytokines - biosynthesis; Dibenzothiepins; Disease Models, Animal; Ducks; Endonuclease; Endonucleases - antagonists & inhibitors; Enzyme Inhibitors - pharmacology; Global health; Humanities and Social Sciences; Humans; Inflammation Mediators - metabolism; Influenza; Influenza A; Influenza A Virus, H7N9 Subtype - drug effects; Influenza A Virus, H7N9 Subtype - enzymology; Influenza in Birds - drug therapy; Influenza in Birds - virology; Influenza, Human - drug therapy; Influenza, Human - metabolism; Influenza, Human - virology; Mice; Morpholines; multidisciplinary; Oral administration; Orthomyxoviridae Infections - drug therapy; Orthomyxoviridae Infections - metabolism; Orthomyxoviridae Infections - virology; Oxazines - pharmacology; Pyridines - pharmacology; Pyridones; Science; Science (multidisciplinary); Thiepins - pharmacology; Triazines - pharmacology; Viral Load; Virus Replication - drug effects; Viruses